查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1584113

戊型肝炎诊断测试市场，按产品类型、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Hepatitis E Diagnostic Tests Market, By Product Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年戊型肝炎诊断测试市场规模为 5,352 万美元，2024 年至 2032 年复合年增长率为 4.80%。

戊型肝炎诊断测试市场-市场动态

早期诊断和及时治疗的需求不断增加，以推动市场需求

近年来，全球戊型肝炎诊断市场经历了重大的技术进步，提高了诊断解决方案的准确性、效率和可近性。例如，2021 年 6 月，DiaSorin 推出了用于戊型肝炎诊断的全自动高通量 CLIA 解决方案，可在接受 CE 标誌的国家使用。这项新产品代表了戊型肝炎诊断的重要改进，使医疗保健提供者能够有效地进行高通量检测。这种能力在戊型肝炎高流行地区尤其重要，在这些地区，快速识别感染者对于有效的疾病管理和预防至关重要。此类先进诊断平台的推出满足了对准确、高效测试解决方案不断增长的需求。努力提高医疗保健提供者、高风险族群和公众的意识对于推动市场成长也至关重要。人们对戊型肝炎的风险和后果（包括孕妇死亡率较高）的认识不断提高，推动了对准确诊断测试的需求。将戊型肝炎检测纳入世界卫生组织 2023 年基本诊断清单，突显了全球对该疾病早期检测和管理重要性的认识。政府和医疗保健系统越来越认识到需要改进监测和疫情管理，从而增加了 HEV 诊断套件的采购。此外，患者和临床医生正在寻求更好地获得戊型肝炎检测，以实现早期诊断和及时治疗，进一步推动市场成长。例如，印度政府全面的国家病毒性肝炎控制计划旨在透过注重预防、诊断和治疗的多管齐下的方法，解决包括戊型肝炎在内的所有形式的病毒性肝炎的负担。该计划涉及大量政府资金和分散实施策略，以增强医疗保健系统有效管理病毒性肝炎的能力。医疗保健支出的增加，特别是在新兴市场，也支持了市场的成长。对早期检测和有效疾病管理的重视正在推动对诊断测试的需求。随着人们对戊型肝炎的认识不断提高，人们更加重视实施预防措施，包括个人卫生、安全水源、适当的卫生设施和食品安全，以减轻病毒的传播。

戊型肝炎诊断测试市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.80% 左右的复合年增长率成长

根据产品类型细分，预计 ELISA HEV IgM 测试将在 2023 年显示最大的市场份额

根据最终用途细分，2023年医院是领先类型

按地区划分，北美是 2023 年的主要收入来源

戊型肝炎诊断测试市场-細項分析：

全球戊型肝炎诊断测试市场根据产品类型、最终用途和地区进行细分。

根据产品类型，市场分为四类：ELISA HEV IgM 测试、ELISA HEV IgG 测试、快速诊断测试和聚合酶链反应 (PCR)。根据类型，ELISA HEV IgM 测试领域在2023 年以最大的收入份额引领戊型肝炎诊断测试市场。发挥关键作用。 IgM 抗体的存在对于诊断急性戊型肝炎至关重要，通常透过后续 RNA 检测来证实。基于 ELISA 的 IgM 检测的高灵敏度和特异性使其成为初次 HEV 筛检的首选。例如，Dia.Pro 提供 HEV-IgM ELISA 检测试剂盒，专门用于检测人类血清或血浆中针对 HEV 的 IgM 抗体。戊型肝炎感染发生率不断上升，特别是在环境卫生和个人卫生习惯不足的发展中地区，显着增加了对 ELISA HEV IgM 检测等有效诊断工具的需求。

根据最终用途，市场分为四大类：医院、血库、诊断实验室和其他最终用户。就最终用途而言，医院细分市场在 2023 年以最大的收入份额引领市场。医院配备了先进的诊断设施、各种医疗保健专业人员以及有效诊断和管理戊型肝炎病例的必要基础设施。此外，医院经常充当更复杂病例的转诊中心，进一步提高其在全球市场中的显着收入份额。

戊型肝炎诊断测试市场 - 地理洞察

该市场迎合了地理上分散的客户群，涵盖北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些地区的参与国家在市场内创造细分市场。 2023 年，北美戊型肝炎诊断测试市场占据重要份额。此外，政府对传染病诊断研究和开发的倡议和资助透过促进新诊断解决方案的开发和采用而有助于市场成长。例如，2024 年4 月，明尼苏达大学荷美尔研究所的Susan Hafenstein 博士从全国儿童医院获得了85,000 美元的NIH 资助，以支持她对HEV 的冷冻电镜研究，目标是为HEV 制定新的治疗和预防策略。

戊型肝炎诊断测试市场-竞争格局：

戊型肝炎诊断测试市场的公司采用各种策略来增强竞争力并扩大市场范围。强调研究和开发至关重要，重点是提高测试灵敏度和特异性，以及创建快速和即时测试解决方案。与医疗机构和实验室的策略合作有助于促进临床验证并促进新测试的广泛采用。行销策略强调早期检测在预防併发症方面的重要性，特别是针对医疗保健提供者和公共卫生机构。此外，公司经常进行教育活动，以提高人们对戊型肝炎风险和检测可用性的认识，确保诊断成为肝臟健康管理不可或缺的一部分。

最新进展：

2023 年 11 月，罗氏推出了两种自动免疫测定法：Elecsys Anti-HEV IgG 和 Elecsys Anti-HEV IgM，旨在检测戊型肝炎病毒感染。这些测试可在承认 CE 标誌的国家/地区进行，包括欧盟成员国。

目录

第一章：戊型肝炎诊断测试市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的戊型肝炎诊断测试市场片段
    • 戊型肝炎诊断测试市场片段（按最终用途）
    • 戊型肝炎诊断测试市场片段（按国家/地区）
    • 按地区分類的戊型肝炎诊断测试市场片段
  • 竞争洞察

第 3 章：戊型肝炎诊断测试主要市场趋势

  • 戊型肝炎诊断测试市场驱动因素
    • 市场驱动因素的影响分析
  • 戊型肝炎诊断测试市场限制
    • 市场限制影响分析
  • 戊型肝炎诊断测试市场机会
  • 戊型肝炎诊断测试市场未来趋势

第 4 章：戊型肝炎诊断测试产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：戊型肝炎诊断测试市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：戊型肝炎诊断测试市场格局

  • 戊型肝炎诊断测试市场占有率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：戊型肝炎诊断测试市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • ELISA HEV IgM 测试
    • ELISA HEV IgG 测试
    • 快速诊断测试
    • 聚合酶炼式反应 (PCR)

第 8 章：戊型肝炎诊断测试市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 诊断实验室
    • 血库
    • 其他最终用户

第 9 章：戊型肝炎诊断测试市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 戊型肝炎诊断测试北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 戊型肝炎诊断测试欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 戊型肝炎诊断测试亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 戊型肝炎诊断测试拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 戊型肝炎诊断测试中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 戊型肝炎诊断测试产业

  • 竞争仪表板
  • 公司简介
    • Altona Diagnostics
    • Dia.Pro Diagnostic Bioprobes srl
    • ELITechGroup
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostics
    • Mikrogen GmbH
    • MP Biomedicals LLP
    • PerkinElmer, Inc
    • Primerdesign Ltd
    • Wantai BioPharm
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4064

REPORT HIGHLIGHT

Hepatitis E Diagnostic Tests Market size was valued at USD 53.52 Million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

Hepatitis E diagnostic tests are medical assays designed to detect the presence of the Hepatitis E virus (HEV), which causes liver inflammation. These tests typically utilize serological methods to identify antibodies (anti-HEV IgM and IgG) or molecular techniques such as PCR polymerase chain reaction (PCR) to detect viral RNA. Early and accurate diagnosis is crucial for managing hepatitis E, especially in pregnant women and individuals with compromised liver function, as the infection can result in severe complications. Hepatitis E diagnostics play a vital role in public health monitoring and controlling outbreaks, particularly in regions where the virus is endemic.

Hepatitis E Diagnostic Tests Market- Market Dynamics

Increasing need of early diagnosis and timely treatment to propel market demand

The global market for hepatitis E diagnostics has experienced significant technological advancements in recent years, enhancing the accuracy, efficiency, and accessibility of diagnostic solutions. For instance, in June 2021, DiaSorin launched fully automated high-throughput CLIA solution for the hepatitis E diagnosis, available in countries that accept the CE mark. This new offering represents a important improvement in hepatitis E diagnostics, allowing healthcare providers to conduct high-throughput testing efficiently. This capability is particularly important in regions with high hepatitis E prevalence, where rapid identification of infected individuals is essential for effective disease management and prevention. The introduction of such advanced diagnostic platforms meets the growing demand for accurate and efficient testing solutions. Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also crucial in driving market growth. Increased awareness of the risks and consequences of hepatitis E, including higher mortality rates in pregnant women, is fueling demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List highlights the global recognition of the importance of early detection and management of the disease. Governments and healthcare systems are increasingly acknowledging the need for improved surveillance and outbreak management, leading to greater procurement of HEV diagnostic kits. Additionally, patients and clinicians are seeking better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For example, the Government of India's comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. This program involves significant government funding and a decentralized implementation strategy to enhance the healthcare system's capacity to manage viral hepatitis effectively. Increasing healthcare expenditure, particularly in emerging markets, is also supporting market growth. The emphasis on early detection and effective disease management is driving demand for diagnostic tests. As awareness about hepatitis E grows, there is a heightened focus on implementing preventive measures, including personal hygiene, safe water sources, proper sanitation, and food safety, to mitigate the virus's spread.

Hepatitis E Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on Product Type segmentation, ELISA HEV IgM test was predicted to show maximum market share in the year 2023

Based on End-use segmentation, the hospital was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hepatitis E Diagnostic Tests Market- Segmentation Analysis:

The Global Hepatitis E Diagnostic Tests Market is segmented on the basis of Product Type, End-use, and Region.

The market is divided into four categories based on product type: ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test and Polymerase Chain Reaction (PCR). Based on type, the ELISA HEV IgM test segment led the hepatitis E diagnostic tests market with the largest revenue share in 2023. This dominance is primarily due to the critical role of detecting IgM-class antibodies to the hepatitis E virus (HEV) for identifying acute or recent infections (less than six months). The presence of IgM antibodies is essential for diagnosing acute hepatitis E, typically confirmed by follow-up RNA testing. The high sensitivity and specificity of ELISA-based IgM tests make them the preferred option for initial HEV screening. For example, Dia.Pro offers the HEV-IgM ELISA test kit, specifically designed to detect IgM antibodies against HEV in human serum or plasma. The increasing incidence of hepatitis E infections, especially in developing regions with inadequate sanitation and hygiene practices, has significantly boosted the demand for effective diagnostic tools like the ELISA HEV IgM test.

The market is divided into four categories based on End use: Hospital, Blood Banks, Diagnostics Laboratories, and Other End User. In terms of end use, the hospital segment was leading the market with the largest revenue share in 2023. This trend is primarily driven by the high prevalence of hepatitis E cases being diagnosed and treated in hospitals globally. Hospitals are equipped with advanced diagnostic facilities, a diverse range of healthcare professionals, and the necessary infrastructure to efficiently diagnose and manage hepatitis E cases. Moreover, hospitals often act as referral centers for more complex cases, further enhancing their significant revenue share in the global market.

Hepatitis E Diagnostic Tests Market- Geographical Insights

This market caters to a geographically scattered customer base, spanning North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Participating nations within these regions create sub-segments within the market. The hepatitis E diagnostic tests market in North America accounted for a significant share in 2023. The region's well-established healthcare infrastructure, comprising hospitals, diagnostic laboratories, and research centers, supports market growth by providing a conducive environment for the adoption of diagnostic tests. Additionally, government initiatives and funding for research and development in infectious disease diagnostics contribute to market growth by facilitating the development and adoption of new diagnostic solutions. For instance, in April 2024, Dr. Susan Hafenstein of The Hormel Institute at the University of Minnesota received an $85,000 NIH-funded grant from Nationwide Children's Hospital to support her cryoEM research into HEV, with the goal of creating new treatments and prevention strategies for hepatitis E.

Hepatitis E Diagnostic Tests Market- Competitive Landscape:

Companies in the hepatitis E diagnostic tests market employ various strategies to enhance competitiveness and expand their market reach. Emphasizing research and development is crucial, with efforts focused on improving test sensitivity and specificity, as well as creating rapid and point-of-care testing solutions. Strategic collaborations with healthcare institutions and laboratories help facilitate clinical validation and promote the widespread adoption of new tests. Marketing strategies highlight the importance of early detection in preventing complications, specifically targeting healthcare providers and public health agencies. Additionally, companies frequently engage in educational initiatives to raise awareness about the risks of hepatitis E and the availability of testing, ensuring that diagnostics become an integral part of liver health management.

Recent Developments:

In November 2023, Roche introduced two automated immunoassays, the Elecsys Anti-HEV IgG and the Elecsys Anti-HEV IgM, designed to detect hepatitis E virus infections. These tests are available in countries that recognize the CE mark, including members of the European Union.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Altona Diagnostics
  • Dia.Pro Diagnostic Bioprobes srl
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • Mikrogen GmbH
  • MP Biomedicals LLP
  • PerkinElmer, Inc
  • Primerdesign Ltd
  • Wantai BioPharm
  • Others

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hepatitis E Diagnostic Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hepatitis E Diagnostic Tests Market Snippet by Product Type
    • 2.1.2. Hepatitis E Diagnostic Tests Market Snippet by End Use
    • 2.1.3. Hepatitis E Diagnostic Tests Market Snippet by Country
    • 2.1.4. Hepatitis E Diagnostic Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. Hepatitis E Diagnostic Tests Key Market Trends

  • 3.1. Hepatitis E Diagnostic Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hepatitis E Diagnostic Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hepatitis E Diagnostic Tests Market Opportunities
  • 3.4. Hepatitis E Diagnostic Tests Market Future Trends

4. Hepatitis E Diagnostic Tests Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hepatitis E Diagnostic Tests Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hepatitis E Diagnostic Tests Market Landscape

  • 6.1. Hepatitis E Diagnostic Tests Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hepatitis E Diagnostic Tests Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. ELISA HEV IgM Test
    • 7.1.3. ELISA HEV IgG Test
    • 7.1.4. Rapid Diagnostics Test
    • 7.1.5. Polymerase Chain Reaction (PCR)

8. Hepatitis E Diagnostic Tests Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 8.1.2. Hospital
    • 8.1.3. Diagnostics Laboratories
    • 8.1.4. Blood Banks
    • 8.1.5. Other End User

9. Hepatitis E Diagnostic Tests Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hepatitis E Diagnostic Tests Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hepatitis E Diagnostic Tests Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hepatitis E Diagnostic Tests Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hepatitis E Diagnostic Tests Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hepatitis E Diagnostic Tests Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hepatitis E Diagnostic Tests Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Altona Diagnostics
    • 10.2.2. Dia.Pro Diagnostic Bioprobes srl
    • 10.2.3. ELITechGroup
    • 10.2.4. F. Hoffmann-La Roche Ltd
    • 10.2.5. Fortress Diagnostics
    • 10.2.6. Mikrogen GmbH
    • 10.2.7. MP Biomedicals LLP
    • 10.2.8. PerkinElmer, Inc
    • 10.2.9. Primerdesign Ltd
    • 10.2.10. Wantai BioPharm
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us